Gomathi Swaminathan | Neuroscience | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Gomathi Swaminathan
JSS College of Pharmacy

Gomathi Swaminathan
Affiliation JSS College of Pharmacy
Country India
Scopus ID 57052775200
Documents 25
Citations 77
h-index 5
Subject Area Neuroscience
Event Top Teachers Awards
ORCID 0000-0003-4458-5445

Gomathi Swaminathan is an academic researcher associated with JSS College of Pharmacy, India, whose scholarly work has contributed to biomedical and clinical research, particularly in areas related to infectious diseases, pharmacotherapy, tuberculosis management, and public health investigations. Through participation in multicenter studies and collaborative clinical research initiatives, Swaminathan has contributed to evidence-based healthcare practices and the advancement of patient-centered therapeutic interventions. The researcher has established a publication record indexed in Scopus and has participated in studies that have generated measurable scientific impact through citations and international visibility.[1]

Abstract

This article presents a scholarly overview of Gomathi Swaminathan and evaluates the research profile, publication contributions, and scientific impact associated with the researcher. The profile demonstrates engagement in collaborative health science investigations, particularly involving tuberculosis diagnostics, HIV-related clinical studies, pharmacokinetics, and public health research. The cumulative research output reflects sustained participation in multidisciplinary projects with measurable academic influence through citations and peer-reviewed publications.[2]

Keywords

Neuroscience, Tuberculosis Research, HIV Studies, Clinical Pharmacology, Public Health, Diagnostics, Biomedical Research, Healthcare Innovation.

Introduction

Academic recognition programs often acknowledge researchers who contribute to scientific advancement through publications, collaborative projects, and evidence-based healthcare research. Gomathi Swaminathan’s work reflects participation in studies addressing major public health challenges, including tuberculosis diagnosis, treatment optimization, nutritional interventions, and infectious disease management. Such contributions support both clinical practice and healthcare policy development.[3]

Research Profile

The research profile of Gomathi Swaminathan includes 25 indexed documents, 77 citations, and an h-index of 5. The researcher has collaborated with multidisciplinary teams across clinical medicine, pharmacology, epidemiology, and healthcare sciences. Publications appearing in internationally recognized journals indicate involvement in studies addressing diagnostic technologies, treatment outcomes, and patient-centered healthcare interventions.[1]

Research Contributions

  • Contributed to multicentre investigations evaluating Truenat tuberculosis diagnostic assays.
  • Participated in pharmacokinetic studies examining efavirenz therapy and genetic polymorphisms.
  • Supported nutritional intervention research among HIV-infected populations.
  • Collaborated on large-scale tuberculosis cohort studies and observational research programs.
  • Contributed to investigations assessing metformin and antituberculosis treatment strategies.

Publications

  1. A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays (2021).
  2. CYP2B6 G516T Polymorphism but Not Rifampin Coadministration Influences Steady-State Pharmacokinetics of Efavirenz (2009).
  3. Nutritional supplementation in HIV-infected individuals in South India (2010).
  4. Cohort for Tuberculosis Research by the Indo-US Medical Partnership (2016).
  5. Evaluation of metformin in combination with rifampicin-containing antituberculosis therapy (2019).

Research Impact

The cited publications have collectively contributed to scientific understanding in tuberculosis diagnostics, HIV treatment, nutritional health, and pharmacological management. The citation record demonstrates recognition from the broader academic community and indicates the relevance of these studies to ongoing healthcare research initiatives. Collaborative engagement across institutions has further expanded the visibility and applicability of the research outcomes.[4]

Award Suitability

Based on publication activity, interdisciplinary collaboration, measurable citation performance, and contributions to clinically relevant research, Gomathi Swaminathan demonstrates characteristics commonly associated with candidates for a Best Researcher Award. The researcher’s involvement in influential studies addressing significant public health challenges supports recognition for scholarly achievement and professional contribution within healthcare research.[5]

Conclusion

Gomathi Swaminathan’s academic record reflects meaningful participation in biomedical and public health research. Through contributions to diagnostic studies, treatment evaluations, and collaborative healthcare investigations, the researcher has supported scientific progress and evidence-based practice. The overall profile aligns with the objectives of academic excellence and research recognition programs.

References

  1. Elsevier. (n.d.). Scopus author details: Gomathi Swaminathan, Author ID 57052775200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57052775200
  2. Penn-Nicholson A, Gomathi SN, et al. (2021). A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays. European Respiratory Journal.
    DOI: https://doi.org/10.1183/13993003.01522-2021
  3. Ramachandran G, Kumar AKH, et al. (2009). CYP2B6 G516T Polymorphism and Efavirenz Pharmacokinetics. Antimicrobial Agents and Chemotherapy.
    DOI: https://doi.org/10.1128/AAC.00999-08
  4. Swaminathan S, Padmapriyadarsini C, et al. (2010). Nutritional supplementation in HIV-infected individuals in South India. Clinical Infectious Diseases.
    DOI: https://doi.org/10.1086/653113
  5. Gupte A, Padmapriyadarsini C, et al. (2016). Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH). BMJ Open.
    DOI: https://doi.org/10.1136/bmjopen-2015-010542
  6. Padmapriyadarsini C, Bhavani PK, et al. (2019). Evaluation of metformin in combination with rifampicin containing antituberculosis therapy (METRIF). BMJ Open.
    DOI: https://doi.org/10.1136/bmjopen-2018-024363